tm logo

Monitor this mark

View On USPTO

OCREVUS
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 12 Feb 2024

Last Applicant/ Owned by

GENENTECH, INC.

1 DNA WAY

SOUTH SAN FRANCISCO

CA

940804990

Serial Number

86205182 filed on 26th Feb 2014

Registration Number

5276659 registered on 29th Aug 2017

in the Principal Register

Correspondent Address

Jelena Libby

Jelena Libby

South San Francisco, CA 94080

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

OCREVUS

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF IMMUNE DISEASES AND DISORDERS AND INFLAMMATORY DISEASES AND DISORDERS

Classification Information

Class [005]
Pharmaceutical Products

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF IMMUNE DISEASES AND DISORDERS AND INFLAMMATORY DISEASES AND DISORDERS

First Use Date in General

01st Apr 2017

First Use Date in Commerce

01st Apr 2017

Mark Details

Serial Number

No 86205182

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM-12638-US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
03rd May 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
03rd May 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03rd May 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03rd May 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12th Feb 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12th Feb 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10th Feb 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22nd Aug 2023TEAS SECTION 8 & 15 RECEIVED
29th Aug 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11th Aug 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED